Sheila Crisostomo – The Philippine Indispensable individual
February 17, 2022 | 12: 00am
MANILA, Philippines — The COVID-19 vaccine of Pfizer-BioNTech is efficient in struggling with Multisystem Inflammatory Syndrome in Children or MIS-C among these aged 12 to 18 years, the Vaccine Educated Panel (VEP) published yesterday.
Citing a peek within the united states among children aged 12-18, VEP head Nina Gloriani noteworthy that MIS-C is a post-COVID situation that on the full occurs two to six weeks after “customarily tender or asymptomatic infections.”
The peek, nonetheless, showed that the estimated effectiveness of two doses of Pfizer vaccine against MIS-C is 91 p.c.
“Quiet and even asymptomatic infections (can) offer you MIS-C. However what they’ve proven is that ought to you give two doses of Pfizer vaccine, it might perchance well possibly well be very efficient in struggling with MIS-C in persons aged 12 to 18 years above,” she urged a forum of the Division of Successfully being.
Gloriani described MIS-C as a “extreme posinfectious hyperinflammatory situation” that is “rare.”
She added that now not unparalleled is identified about how MIS-C comes about, but it involves different organs of the body such as the coronary heart, brain and respiratory machine.
“It’s doubtlessly also linked to how the immune machine reacts,” she said.
The peek became performed among minors aged 12-18 who were hospitalized from July to December 2021.
The expert also said that 95 p.c of children hospitalized with MIS-C were unvaccinated.
“Those who were vaccinated but additionally had microscopic MIS-C required no existence strengthen. This suggests they failed to growth into extreme or important infection,” she said.
In the absence of ample data, Gloriani said that Pfizer vaccine doubtlessly would now not allow the virus to repeat “so you is now not going to elicit that inflammatory response.”
Ideal evening, one other 780,000 doses of pediatric Pfizer vaccine procured by the authorities were put to advance on the Ninoy Aquino Worldwide Airport (NAIA) Terminal 3.
Tonight, a cargo of 455,130 Pfizer jabs for ages 12 and up can even advance on the NAIA through Air Hong Kong flight LD456 from the COVAX Facility. – Rudy Santos